Controversy: Radiotherapy for acromegaly

Clinical Endocrinology

Volumn 58, Issue 2, 2003, Pages 136-137

  Thorner, Michael O ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; GAMMA KNIFE RADIOSURGERY; HORMONE BLOOD LEVEL; HUMAN; MEDICAL DECISION MAKING; MICROADENOMA; MORBIDITY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; SAFETY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR GROWTH;

ACROMEGALY; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; PATIENT SELECTION; PITUITARY IRRADIATION; PITUITARY NEOPLASMS; RADIOSURGERY; TREATMENT OUTCOME;

EID: 0037322216     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01705.x     Document Type: Note

References (1)

1. van der Lely, A.J., Hutson, R.K., Trainer, P.J., Besser, G.M., Barkan, A.L., Klibanski, A., Herman-Bonert, V., Melmed, S., Vance, M.L., Freda, P.U., Stewart, P.M., Friend, K.E., Clemmons, D.R., Johannsson, G., Kleinberg, D.L., Cook, D.M., Phillips, L.S., Strasburger, C.J., Hackett, S., Zib, K.A., Davis, R.J., Scarlett, J.A. & Thorner, M.O. (2001) Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. The Lancet, 358, 1754-1759.